Method of treating rhabdomyolysis by administering hepatocyte growth factor
US6436388B2 · kind B2 · utility
5Cited by
3References
2Claims
0Family size
Inventors
Key dates
| Filing date | Feb 24, 2000 |
| Grant date | Aug 20, 2002 |
| Priority date | — |
| Expiry date | Feb 24, 2020 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is drawn to a method of treating acute renal failure caused by rhabdomyolysis by administering a therapeutically effective amount of hepatocyte growth factor (HGF). The present invention is further drawn to a method of treating rhabdomyolysis by administering a therapeutically effective amount of hepatocyte growth factor (HGF).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.